JP Morgan Chase’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.31B | Buy |
8,503,527
+1,708,045
| +25% | +$820M | 0.24% | 86 |
|
|
2026
Q1 | $3.26B | Buy |
6,795,482
+183,604
| +3% | +$99.6M | 0.21% | 103 |
|
|
2025
Q4 | $3.83B | Sell |
6,611,878
-661,431
| -9% | -$374M | 0.24% | 93 |
|
|
2025
Q3 | $3.53B | Sell |
7,273,309
-1,880,759
| -21% | -$875M | 0.21% | 103 |
|
|
2025
Q2 | $3.71B | Sell |
9,154,068
-983,712
| -10% | -$411M | 0.24% | 90 |
|
|
2025
Q1 | $5.04B | Buy |
10,137,780
+1,219,546
| +14% | +$661M | 0.37% | 52 |
|
|
2024
Q4 | $4.64B | Buy |
8,918,234
+2,311,325
| +35% | +$1.27B | 0.35% | 54 |
|
|
2024
Q3 | $4.09B | Buy |
6,606,909
+982,760
| +17% | +$582M | 0.31% | 61 |
|
|
2024
Q2 | $3.11B | Buy |
5,624,149
+1,205,711
| +27% | +$691M | 0.26% | 82 |
|
|
2024
Q1 | $2.57B | Buy |
4,418,438
+643,385
| +17% | +$361M | 0.22% | 99 |
|
|
2023
Q4 | $2B | Sell |
3,775,053
-284,856
| -7% | -$138M | 0.19% | 117 |
|
|
2023
Q3 | $2.06B | Sell |
4,059,909
-1,042,569
| -20% | -$556M | 0.23% | 100 |
|
|
2023
Q2 | $2.66B | Sell |
5,102,478
-278,440
| -5% | -$150M | 0.29% | 83 |
|
|
2023
Q1 | $3.1B | Buy |
5,380,918
+202,442
| +4% | +$114M | 0.38% | 59 |
|
|
2022
Q4 | $2.85B | Sell |
5,178,476
-357,912
| -6% | -$190M | 0.38% | 55 |
|
|
2022
Q3 | $2.81B | Buy |
5,536,388
+397,995
| +8% | +$223M | 0.4% | 48 |
|
|
2022
Q2 | $2.79B | Buy |
5,138,393
+122,750
| +2% | +$67.6M | 0.39% | 57 |
|
|
2022
Q1 | $2.96B | Buy |
5,015,643
+171,812
| +4% | +$98.7M | 0.36% | 57 |
|
|
2021
Q4 | $3.23B | Buy |
4,843,831
+308,010
| +7% | +$192M | 0.37% | 54 |
|
|
2021
Q3 | $2.59B | Sell |
4,535,821
-16,732
| -0.4% | -$9.18M | 0.32% | 64 |
|
|
2021
Q2 | $2.3B | Sell |
4,552,553
-8,123
| -0.2% | -$3.83M | 0.27% | 76 |
|
|
2021
Q1 | $2.08B | Buy |
4,560,676
+53,008
| +1% | +$25.3M | 0.28% | 75 |
|
|
2020
Q4 | $2.1B | Sell |
4,507,668
-283,962
| -6% | -$133M | 0.31% | 67 |
|
|
2020
Q3 | $2.08B | Sell |
4,791,630
-245,139
| -5% | -$101M | 0.35% | 56 |
|
|
2020
Q2 | $1.83B | Sell |
5,036,769
-315,722
| -6% | -$106M | 0.35% | 53 |
|
|
2020
Q1 | $1.52B | Buy |
5,352,491
+72,537
| +1% | +$22.9M | 0.36% | 60 |
|
|
2019
Q4 | $1.72B | Sell |
5,279,954
-377,442
| -7% | -$114M | 0.32% | 64 |
|
|
2019
Q3 | $1.65B | Buy |
5,657,396
+174,292
| +3% | +$49.9M | 0.33% | 59 |
|
|
2019
Q2 | $1.61B | Buy |
5,483,104
+2,040,009
| +59% | +$562M | 0.32% | 58 |
|
|
2019
Q1 | $942M | Sell |
3,443,095
-699,249
| -17% | -$174M | 0.19% | 112 |
|
|
2018
Q4 | $927M | Buy |
4,142,344
+1,307,230
| +46% | +$307M | 0.21% | 103 |
|
|
2018
Q3 | $692M | Buy |
2,835,114
+560,121
| +25% | +$129M | 0.13% | 164 |
|
|
2018
Q2 | $471M | Buy |
2,274,993
+135,311
| +6% | +$28.7M | 0.1% | 221 |
|
|
2018
Q1 | $442M | Sell |
2,139,682
-1,028,800
| -32% | -$216M | 0.09% | 234 |
|
|
2017
Q4 | $602M | Buy |
3,168,482
+672,756
| +27% | +$129M | 0.13% | 171 |
|
|
2017
Q3 | $465M | Buy |
2,495,726
+453,998
| +22% | +$82.2M | 0.1% | 220 |
|
|
2017
Q2 | $356M | Sell |
2,041,728
-106,314
| -5% | -$17.9M | 0.08% | 261 |
|
|
2017
Q1 | $330M | Sell |
2,148,042
-589,440
| -22% | -$90.1M | 0.08% | 268 |
|
|
2016
Q4 | $387M | Buy |
2,737,482
+228,529
| +9% | +$33.7M | 0.09% | 231 |
|
|
2016
Q3 | $400M | Sell |
2,508,953
-45,698
| -2% | -$7.04M | 0.1% | 231 |
|
|
2016
Q2 | $377M | Buy |
2,554,651
+600,716
| +31% | +$88.7M | 0.09% | 242 |
|
|
2016
Q1 | $277M | Buy |
1,953,935
+620,110
| +46% | +$83.1M | 0.07% | 294 |
|
|
2015
Q4 | $189M | Buy |
1,333,825
+334,756
| +34% | +$44.6M | 0.05% | 402 |
|
|
2015
Q3 | $122M | Sell |
999,069
-291,999
| -23% | -$38M | 0.03% | 490 |
|
|
2015
Q2 | $168M | Buy |
1,291,068
+28,328
| +2% | +$3.69M | 0.04% | 448 |
|
|
2015
Q1 | $170M | Buy |
1,262,740
+387,440
| +44% | +$49.9M | 0.04% | 474 |
|
|
2014
Q4 | $110M | Sell |
875,300
-119,547
| -12% | -$14.5M | 0.03% | 603 |
|
|
2014
Q3 | $121M | Buy |
994,847
+41,401
| +4% | +$5.03M | 0.03% | 553 |
|
|
2014
Q2 | $113M | Sell |
953,446
-135,341
| -12% | -$15.9M | 0.03% | 532 |
|
|
2014
Q1 | $131M | Buy |
1,088,787
+23,408
| +2% | +$2.78M | 0.04% | 475 |
|
|
2013
Q4 | $119M | Sell |
1,065,379
-593,586
| -36% | -$59M | 0.03% | 470 |
|
|
2013
Q3 | $153M | Sell |
1,658,965
-25,166
| -1% | -$2.28M | 0.05% | 410 |
|
|
2013
Q2 | $143M | Buy |
+1,684,131
| New | +$140M | 0.05% | 401 |
|
Other funds holding TMO
JP Morgan Chase's TMO Position: Q2 2026 in Review
JP Morgan Chase increased its Thermo Fisher Scientific (TMO) stake by 25% in Q2 2026, buying an estimated $820M and bringing the position to 8,503,527 shares worth $4.31B. The position accounts for 0.24% of the portfolio, ranked #86.
JP Morgan Chase first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.04B in Q1 2025. 2,022 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- JP Morgan Chase held 8,503,527 shares of Thermo Fisher Scientific worth $4.31B as of Q2 2026.
- JP Morgan Chase bought 1,708,045 Thermo Fisher Scientific shares in Q2 2026, an estimated $820M.
- Thermo Fisher Scientific made up 0.24% of JP Morgan Chase's portfolio in Q2 2026, its #86 holding.
- JP Morgan Chase first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- JP Morgan Chase's Thermo Fisher Scientific position peaked at $5.04B in Q1 2025.
- 2,022 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.